# Crystal Pharmatech

> Crystal Pharmatech is a VC fund in Suzhou backing Health Care and Outsourcing. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Suzhou, China
- Total investments: 1
- Last investment: Jan 2018
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/crystal-pharmatech-inc/
- Website: http://www.crystalpharmatech.com.cn/

Crystal Pharmatech is a solid-state drug development firm.

## Contacts

5 contacts available for Crystal Pharmatech. Shizune tracks 2 team members at Crystal Pharmatech. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/crystal-pharmatech?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Outsourcing | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Minhua Chen | Co-Founder & Chief Executive Officer | 0 | — |
| Yanfeng Zhang | Co-Founder & Chief Scientific Officer | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Laviana Pharma | Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products fromlaboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States. | $15M | Series B | Jan 02, 2018 |  |

1 of 1 investments shown.

## Co-investors
- ABC Capital — VC Fund, 1 deal together
- [HY Capital](https://shizune.co/investors/profile/hy-capital) — VC Fund, 1 deal together
- [LYFE Capital](https://shizune.co/investors/profile/lyfe-capital-2) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Crystal Pharmatech invest in?

Crystal Pharmatech invests primarily in Health Care, Outsourcing and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Crystal Pharmatech?

Public channels for Crystal Pharmatech include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Crystal Pharmatech?

The team at Crystal Pharmatech includes Minhua Chen (Co-Founder & Chief Executive Officer) and Yanfeng Zhang (Co-Founder & Chief Scientific Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co